| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,433,000 | 4,018,000 | 3,691,000 | 4,547,000 | | Cost of Revenue | 3,441,000 | 3,259,000 | 3,503,000 | 4,557,000 | | | Gross Profit | 992,000 | 759,000 | 188,000 | (10,000) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 641,000 | 342,000 | 118,000 | 415,000 | | Non Recurring | 43,000 | 88,000 | 119,000 | 125,000 | | Others | 220,000 | 222,000 | 233,000 | 262,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 88,000 | 107,000 | (282,000) | (812,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,000) | 40,000 | 1,000 | (357,000) | | Earnings Before Interest And Taxes | 81,000 | 147,000 | (281,000) | (1,169,000) | | Interest Expense | 143,000 | 133,000 | 131,000 | 131,000 | | Income Before Tax | (62,000) | 14,000 | (412,000) | (1,300,000) | | Income Tax Expense | (4,000) | (13,000) | (29,000) | 5,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (57,000) | 28,000 | (382,000) | (1,303,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (57,000) | 28,000 | (382,000) | (1,303,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($57,000) | $28,000 | ($382,000) | ($1,303,000) |
|
1.48% Nasdaq 
Income Statement
